Peipei Wu

2.7k total citations · 2 hit papers
62 papers, 2.0k citations indexed

About

Peipei Wu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Peipei Wu has authored 62 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 16 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Peipei Wu's work include Extracellular vesicles in disease (24 papers), MicroRNA in disease regulation (12 papers) and Mesenchymal stem cell research (7 papers). Peipei Wu is often cited by papers focused on Extracellular vesicles in disease (24 papers), MicroRNA in disease regulation (12 papers) and Mesenchymal stem cell research (7 papers). Peipei Wu collaborates with scholars based in China, United States and United Kingdom. Peipei Wu's co-authors include Hui Qian, Wenrong Xu, Bin Zhang, Hui Shi, Cheng Ji, Dickson Kofi Wiredu Ocansey, Yaoxiang Sun, Siqi Yin, Xu Zhang and Fei Mao and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Peipei Wu

55 papers receiving 2.0k citations

Hit Papers

Human Mesenchymal Stem Cell Derived Exosomes Alleviate Ty... 2018 2026 2020 2023 2018 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peipei Wu China 24 1.4k 654 310 243 175 62 2.0k
Jia Cao China 19 1.6k 1.1× 544 0.8× 215 0.7× 338 1.4× 271 1.5× 35 2.2k
Yaoxiang Sun China 17 1.2k 0.9× 570 0.9× 331 1.1× 189 0.8× 229 1.3× 23 1.6k
Xia Liu China 23 699 0.5× 442 0.7× 263 0.8× 396 1.6× 164 0.9× 94 2.0k
Xiaoning He China 23 873 0.6× 283 0.4× 578 1.9× 295 1.2× 169 1.0× 72 2.2k
Radhakrishnan Vishnubalaji Qatar 25 1.3k 0.9× 816 1.2× 432 1.4× 259 1.1× 43 0.2× 54 2.2k
Giovanni Zito Italy 17 947 0.7× 364 0.6× 180 0.6× 164 0.7× 100 0.6× 72 1.8k
Yan Han China 18 720 0.5× 284 0.4× 340 1.1× 341 1.4× 211 1.2× 99 1.5k
Ming Shi China 21 626 0.5× 292 0.4× 395 1.3× 229 0.9× 106 0.6× 60 1.5k
Mujib Ullah United States 24 1.1k 0.8× 459 0.7× 444 1.4× 308 1.3× 43 0.2× 63 2.0k
Abdullah Aldahmash Saudi Arabia 27 1.5k 1.1× 846 1.3× 732 2.4× 400 1.6× 50 0.3× 72 2.6k

Countries citing papers authored by Peipei Wu

Since Specialization
Citations

This map shows the geographic impact of Peipei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peipei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peipei Wu more than expected).

Fields of papers citing papers by Peipei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peipei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peipei Wu. The network helps show where Peipei Wu may publish in the future.

Co-authorship network of co-authors of Peipei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Peipei Wu. A scholar is included among the top collaborators of Peipei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peipei Wu. Peipei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Elsaleh, Tarek, Peipei Wu, Franck Le Gall, et al.. (2025). A decentralised architecture for secure exchange of assets in data spaces: The case of SEDIMARK. Data in Brief. 61. 111757–111757.
3.
Shen, Ye, Xueyan Zang, Peipei Wu, et al.. (2025). Neutrophil membrane engineered human umbilical cord MSC-derived sEVs enhance anti-tumor efficacy for gastric cancer via delivering pentraxin 3. Journal of Controlled Release. 383. 113828–113828. 3 indexed citations
4.
Wu, Peipei, Wenjuan Huang, Jiao Feng, Guoping Chen, & Ying Sun. (2025). Parental acceptance of school-based universal depression screening for children and adolescents in primary and secondary school in China. BMC Public Health. 25(1). 101–101.
6.
Sun, Zixuan, Yu Li, Yong Zheng, et al.. (2024). Mesenchymal stromal cells-derived small extracellular vesicles protect against UV-induced photoaging via regulating pregnancy zone protein. Stem Cells Translational Medicine. 13(11). 1129–1143. 3 indexed citations
7.
Wang, Min, Dakai Yang, Peipei Wu, et al.. (2024). A Dual Role of Mesenchymal Stem Cell Derived Small Extracellular Vesicles on TRPC6 Protein and Mitochondria to Promote Diabetic Wound Healing. ACS Nano. 18(6). 4871–4885. 26 indexed citations
8.
Wu, Peipei, Jing Li, Yi Zhou, et al.. (2024). Effectiveness of a universal resilience-focused intervention for children in the school setting: A randomized controlled trial. Journal of Affective Disorders. 368. 695–703. 2 indexed citations
9.
Jin, Can, et al.. (2024). Engineered Nanoparticles for Theranostic Applications in Kidney Repair. Advanced Healthcare Materials. 14(1). e2402480–e2402480. 2 indexed citations
10.
Yu, Lu, Jintao Wang, Peipei Wu, et al.. (2023). Prognostic nomogram for patients with tongue squamous cell carcinoma: A SEER ‐based study. Oral Diseases. 30(2). 292–306. 1 indexed citations
11.
Kitagawa, Munenori, et al.. (2022). An RNA exosome subunit mediates cell-to-cell trafficking of a homeobox mRNA via plasmodesmata. Science. 375(6577). 177–182. 37 indexed citations
12.
Sun, Zixuan, et al.. (2022). Diagnostic and Therapeutic Roles of Extracellular Vesicles in Aging‐Related Diseases. Oxidative Medicine and Cellular Longevity. 2022(1). 6742792–6742792. 12 indexed citations
14.
Wang, Min, Peipei Wu, Wenhui Liu, et al.. (2022). Skin cell-derived extracellular vesicles: a promising therapeutic strategy for cutaneous injury. Burns & Trauma. 10. tkac037–tkac037. 20 indexed citations
15.
Sun, Zixuan, et al.. (2021). Roles of Mesenchymal Stem Cell-Derived Exosomes in Cancer Development and Targeted Therapy. Stem Cells International. 2021. 1–10. 29 indexed citations
16.
Zhang, Bin, Hui Shi, Rong Li, et al.. (2019). The Role of CDR1as in Proliferation and Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells. Stem Cells International. 2019. 1–11. 26 indexed citations
17.
Sun, Yaoxiang, Hui Shi, Siqi Yin, et al.. (2018). Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. ACS Nano. 12(8). 7613–7628. 354 indexed citations breakdown →
18.
Zhang, Rongxue, Lei Yin, Bin Zhang, et al.. (2018). Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death and Disease. 9(10). 965–965. 42 indexed citations
19.
Wu, Peipei, et al.. (2016). Development of training contents in sexual health for postoperative breast cancer patients. 51(11). 1329. 1 indexed citations
20.
Xing, Ligang, Jiandong Zhang, Peipei Wu, et al.. (2014). Definitive chemoradiotherapy with capecitabine and cisplatin for elder patients with locally advanced squamous cell esophageal cancer. Journal of Cancer Research and Clinical Oncology. 140(5). 867–872. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026